论文部分内容阅读
我科于１９９７年４月至１９９７年９月对安卡（马蔺子素）胶囊合并放射（简称综合组），治疗恶性肿瘤与单纯放疗（简称单放组），进行了Ⅲ期临床研究，现将结果报告如下。１ 一般资料１．１ 临床资料与方法全组共１４０例，综合组及单放组各７０例，综合组男性５４例，女性?
In our department from April 1997 to September 1997, Phase III clinical trials were conducted on Anka (Mavistin) capsule combined radiation (referred to as the comprehensive group) for the treatment of malignant tumors and radiotherapy alone (referred to as single-release group). The results are reported below. 1 General Information 1.1 Clinical data and methods A total of 140 cases in the whole group, 70 cases in the comprehensive group and the radiotherapy group, and 54 cases in the integrated group.